Through synthetic lethality screening using a chemical library for isogenic cell lines with and without oncogenic KRAS, we previously reported a small molecule, designated oncrasin-1, that induces apoptosis in several KRAS-mutant lung cancer cell lines [186]. This evidence concerns the gene KRAS and lung carcinoma.